These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 1746000)

  • 21. Thrombin binding to platelet membrane glycoprotein Ib.
    Jandrot-Perrus M; Huisse MG; Ternisien C; Bezeaud A; Guillin MC
    Semin Thromb Hemost; 1992; 18(2):261-6. PubMed ID: 1631575
    [No Abstract]   [Full Text] [Related]  

  • 22. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha.
    De Marco L; Mazzucato M; Masotti A; Ruggeri ZM
    J Biol Chem; 1994 Mar; 269(9):6478-84. PubMed ID: 8119999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY
    J Biol Chem; 1990 Dec; 265(36):22159-66. PubMed ID: 2266119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of phosphopyridoxylation on thrombin interaction with platelet glycoprotein Ib.
    Ternisien C; Jandrot-Perrus M; Huisse MG; Guillin MC
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):521-8. PubMed ID: 1768765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombin interaction with platelet glycoprotein Ib: effect of glycocalicin on thrombin specificity.
    Jandrot-Perrus M; Clemetson KJ; Huisse MG; Guillin MC
    Blood; 1992 Dec; 80(11):2781-6. PubMed ID: 1450405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric antithrombin peptide. Characterization of an Arg-Gly-Asp (RGD)- and hirudin carboxyl terminus-containing synthetic peptides.
    Church FC; Phillips JE; Woods JL
    J Biol Chem; 1991 Jun; 266(18):11975-9. PubMed ID: 2050691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY
    Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant peptides: nature of the interaction of the C-terminal region of hirudin with a noncatalytic binding site on thrombin.
    Krstenansky JL; Owen TJ; Yates MT; Mao SJ
    J Med Chem; 1987 Sep; 30(9):1688-91. PubMed ID: 3625715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of the protein C activation peptide with platelets.
    Martínez-Cruz R; Canseco Mdel S; Lopez-Martínez J; Cruz PA; Pérez-Campos E; Cruz MM; Alva FC; Majluf-Cruz A; Zenteno E; Ruiz-Argüelles A
    Prep Biochem Biotechnol; 2007; 37(2):139-47. PubMed ID: 17454824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interactions involving C-terminal nonpolar residues of hirudin in the formation of the thrombin-hirudin complex.
    Betz A; Hofsteenge J; Stone SR
    Biochemistry; 1991 Oct; 30(41):9848-53. PubMed ID: 1911777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceleration of Ca2+ ionophore-induced arachidonic acid liberation by thrombin without the proteolytic action toward the receptor in human platelets.
    Akiba S; Kawauchi T; Sato T
    Eur J Biochem; 1999 Feb; 259(3):643-50. PubMed ID: 10092848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complexes of thrombin with proteins secreted by activated platelets.
    Detwiler TC; Chang AC; Speziale MV; Browne PC; Miller JJ; Chen K
    Semin Thromb Hemost; 1992 Jan; 18(1):60-6. PubMed ID: 1315454
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombin binding to platelets and their activation in plasma.
    Liu L; Freedman J; Hornstein A; Fenton JW; Ofosu FA
    Br J Haematol; 1994 Nov; 88(3):592-600. PubMed ID: 7529534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J; Stöhr HA; Stauss H; Koschinsky R; Stüber W; Pâques EP
    Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity alpha-thrombin binding to platelet glycoprotein Ib alpha: identification of two binding domains.
    Gralnick HR; Williams S; McKeown LP; Hansmann K; Fenton JW; Krutzsch H
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6334-8. PubMed ID: 8022782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib.
    De Cristofaro R; De Candia E; Landolfi R; Rutella S; Hall SW
    Biochemistry; 2001 Nov; 40(44):13268-73. PubMed ID: 11683636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet responses to compound interactions with thrombin.
    Smith RD; Owen WG
    Biochemistry; 1999 Jul; 38(28):8936-47. PubMed ID: 10413467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of thrombin by synthetic hirudin peptides.
    Binnie CG; Erickson BW; Hermans J
    FEBS Lett; 1990 Sep; 270(1-2):85-9. PubMed ID: 2226793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.